Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
April 21, 2021 - 5 minutes
Victor Kotsev
Victor Kotsev is a reporter-at-large. He does all things business, technology, and international politics, with a special focus on health and biotech. He has spent most of the 2010s covering the Balkans and the Middle East for the likes of USA Today, Globe and Mail, and Fast Company, primarily out of Istanbul.
Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
March 25, 2021 - 6 minutes
How to Negotiate a Successful Research Collaboration Agreement
Negotiating the terms of a research collaboration can be a minefield. Life sciences attorney Lori…
March 24, 2021 - 9 minutes
Galapagos and Gilead Soldier On After Inflammatory Disease Flops
Clinical and regulatory setbacks have left the star biotech duo Gilead and Galapagos smarting and…
March 4, 2021 - 4 minutes
Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B
This month’s €6B acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been…
February 18, 2021 - 6 minutes
How Much Control Should Investors Have Over Your Biotech Company?
While getting funding from a star investor can be great for business, many biotech entrepreneurs…
January 13, 2021 - 6 minutes
Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
December 21, 2020 - 5 minutes
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
December 17, 2020 - 6 minutes
EU Launches Pharma Strategy, Raising Both Hopes and Questions
The public's response has been cautious after the European Union unveiled a pharmaceutical strategy last…
December 4, 2020 - 6 minutes
uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy
Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer…
November 27, 2020 - 5 minutes
How to Weather Bad Press as a Biotech Company
Biomedical companies face unique challenges when it comes to media communication. Crisis communication, in particular,…
November 25, 2020 - 7 minutes
2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…
October 9, 2020 - 4 minutes
